跳至主要内容
临床试验/ISRCTN12666644
ISRCTN12666644已完成不适用

Efficacy of Metered Dose Inhaler (MDI) with attached Bottle spacer for bronchodilator therapy in infants and young children with acute lower airways obstruction (South Africa)

The Department of Child and Adolescent Health (CAH)/World Health Organization (WHO) (Switzerland)0 个研究点目标入组 396 人开始时间: 2004年7月28日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
396

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 3 months to 5 years
  • 2. Able to use MDI - spacer as assessed by the researcher administering inhaled treatment
  • 3. Acute episode of lower airway obstruction (wheezing or hyperinflation)
  • 4. Informed consent of parent/guardian

排除标准

  • 1. Use of bronchodilator within the preceeding 4 hours
  • 2. Known underlying cardiac or chronic pulmonary disease (other than asthma)
  • 3. Presence of stridor or daily treatment with oral corticosteroids for more than 2 days prior

研究者

发起方
The Department of Child and Adolescent Health (CAH)/World Health Organization (WHO) (Switzerland)

相似试验